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fibroblasts. The impairment of proton-translocation activity of COX was
directly confirmed by mitochondrial membrane potential measure-
ments using TPP+ electrode. While proton pumping at complexes I and
III in patient fibroblasts was similar to controls, ascorbate + TMPD
substrates were unable to support generation of proton gradient.
Consequently, mitochondrial membrane potential as estimated by JC-1
staining was lower in intact patient fibroblasts, leading to extremely
decreased rates of mitochondrial ATP production to 25% of control
values. Such drop in energy provision ultimately resulted in two-fold
decrease of ATP/ADP ratio in patient cells grown in galactose medium,
when most of ATP must be synthesized by mitochondria. In contrast to
profound impairment of mitochondrial energetics, no changes in the
production of reactive oxygen species (ROS) or antioxidant defences
could be found in patient fibroblasts. This is perhaps due to decreased
mitochondrial membrane potential, which may serve as a paradoxical
ROS-preventing mechanism. We conclude that unlike to mitochondrial
disorders caused by dysfunction of ATPase or complex I, the pathogenic
mechanism of COX deficiencies seems to have only single component—
impaired mitochondrial energy provision.
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Genetic defects in enzymes of oxidative phosphorylation cause a
broad spectrum of mitochondrial encephalomyopathies. Apart from
diminished ATP production per se, elevated oxidative stress is
implicated in pathogenic mechanism of mitochondrial diseases. In our
work we used fibroblasts from patients with isolated deficiency of ATP
synthase caused bymutation inTMEM70gene to study consequences on
mitochondrial function, in vivoROSproduction and levels of cellular ROS
scavengers.With the aim to elucidate how the lowATP synthase content
affectsmitochondrial energy provision,we have investigated fibroblasts
from patients with ATP synthase content decreased to <30% of the
control. Measurements of cellular respiration showed insufficient ATP
synthase capacity for basal respiration andmitochondrial ATP synthesis
was decreased to 26–33%.Cytofluorometric analysis using TMRM
revealed increased mitochondrial membrane potential (Δψm) at state
3-ADP in patient cells. Consequently, viability of patient fibroblasts was
more sensitive to ATP synthase inhibitors oligomycin or aurovertin.
Analysis of ROS production by CM-H2DCFDA demonstrated increase in
ROS production and decrease of MnSOD activity in two patients, while
level of main cellular ROS scavenger glutathione was only mildly
decreased compared to control. In the third patient ROS productionwas
not changed but MnSOD activity was dramatically increased and
glutathione level decreased. Our results indicate two-component
pathological mechanisms in ATP synthase deficient patient cells —
impairment of ATP provision and oxidative stress.
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Mutations in nuclear genes encoding proteins that are involved in
mitochondrial DNA (mtDNA) maintenance, e.g. POLG, TK2, are
associated with various neurodegenerative disorders [1]. All patho-
genic mutations in these nuclear genes lead to mtDNA depletion and
secondary mtDNA mutations, which cause dysfunction of the
oxidative phosphorylation and lead to disease phenotype. Until
now it is a major challenge to demonstrate the direct functional
consequences of those mutations. To address the issue, whether POLG
or TK2 mutations lead to impaired mtDNA maintenance, a kinetic
assay for mtDNA replication in primary human fibroblasts was
performed. Different fibroblast cell lines were depleted of their
mtDNA by treatment with ethidium bromide (EtBr) and the rates of
mtDNA repopulationwere determined. Here we demonstrate that the
rate of mtDNA depletion, induced by EtBr, showed no significant
difference between patients and controls. In contrast, the restoration
of mtDNA levels is significantly delayed in fibroblasts from patients
with POLG mutations, while TK2 mutations have no effect on mtDNA
repopulation rates. These findings provide the first in vivo evidence
that pathogenic POLG mutations directly influence the mtDNA
maintenance in human cells. Furthermore, these results are in line
with in vitro data showing reduced catalytic activity and processivity
for several pathogenic POLG alleles [2–5].
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Diabetes is a mitochondrial disease. Atherosclerotic coronary
artery disease (CAD) is the leading cause of mortality in diabetic
patients. Mitochondrial dysfunction and increased production of
reactive oxygen species (ROS) are associated with diabetes and CAD.
Elevated levels of glycated low density lipoproteins (glyLDL) and
oxidized LDL (oxLDL) were detected in patients with diabetes. Our
previous studies demonstrated that oxLDL and glyLDL increased the
generation of ROS and altered the activities of antioxidant enzymes in
vascular endothelial cells (EC). The present study examined the
effects of glyLDL and oxLDL on oxygen consumption in mitochondria
and the activities of key enzymes in mitochondrial electron transport
chain (ETC) in cultured porcine aortic EC. The results demonstrated
that glyLDL or oxLDL significantly impaired oxygen consumption in
Complex I, II/III and IV of mitochondrial ETC in EC compared to LDL or
vehicle control detected using oxygraphy. Incubation with glyLDL or
oxLDL significantly reduced mitochondrial membrane potential, the
levels of NAD+/NADH ratio, and the activities of mitochondrial ETC
enzymes (NADH–ubiquinone dehydrogenase, succinate cytochrome c
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reductase, ubiquinone cytochrome c reductase, and cytochrome c
oxidase) in EC compared to LDL or control. The abundance of
mitochondria-associated ROS and the release of ROS from EC were
significantly increased following glyLDL or oxLDL treatment. The
findings suggest that glyLDL attenuates activities of key enzymes in
multiple mitochondrial ETC, decreases mitochondrial oxygen con-
sumption and mitochondrial membrane potential, and increases ROS
generation from mitochondria in EC, which potentially contributes to
mitochondrial dysfunction and vascular disorders in diabetic patients.
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In humans, deficiency of complex I (CI or NADH:ubiquinone
oxidoreductase) is associated with a wide range of progressive
neurological disorders that are characterized by an early onset and a
short devastating course. CI resides in the mitochondrial inner
membrane (MIM), where it channels electrons from food-derived
NADH into the electron transport chain (ETC). Together with three
other complexes (CII-CIV) and the ATP-generating enzyme FOF1-
ATPase (CV), CI constitutes the mitochondrial oxidative phosphoryla-
tion system (OXPHOS). CI is a large (about 1 MDa) multi-subunit
complex that consists of 45 different subunits of which 7 are encoded
by the mitochondrial DNA (mtDNA) and the remainder by the
nuclear DNA (nDNA). To study the pathophysiology of CI dysfunction,
we use a novel knockout (KO) mouse model lacking an nDNA-
encoded CI subunit (NDUFS4), which is a mutational hotspot in
human CI deficiency. For this purpose we generated mouse
embryonic fibroblast (MEF) cell lines from wild type (WT) and KO
animals. Analysis of mitochondrial fractions revealed a greatly
reduced CI activity in KO MEFs (about 5% of WT), whereas other
activities (CII, CIII, CIV, CV and citrate synthase) were normal. At the
protein level, MEFs from KO animals lacked fully assembled CI but
instead contained a CI subcomplex of about 850 kDa. Reintroduction
of the NDUFS4 subunit in KO cells led to reappearance of the fully
assembled CI holocomplex. Functionally, KO MEFs contained mito-
chondria with a hyperpolarized membrane potential, probably due to
reverse-mode action of CV. When cultured in glucose-containing
(GLU) medium, reactive oxygen species (ROS) levels in WT and KO
cells were identical. However, when a galactose (GAL) medium was
used, KO MEFs displayed increased ROS levels whereas WT MEFs did
not. In KO MEFs, complementation of the NDUFS4 gene defect fully
normalized the increased ROS levels. NADP(H) levels in KO MEFs
were higher than in WT MEFs, whereas cytosolic resting [ATP]
(determined with the novel fluorescent ATP-sensor ‘ATeam’) where
the same. Currently, experiments are in progress to determine the
effects of NDUFS4 knockout on cytosolic calcium handling and
expression of energy-sensing proteins. Moreover, established anti-
oxidants and nutraceuticals are tested for their beneficial action on
WT and KO MEFs.
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Riboflavin-responsive multiple acyl-CoA dehydrogenase defi-
ciency (RR-MAD) is a lipid storage myopathy characterised by muscle
weakness, decreased β-oxidation and muscle carnitine, altered
urinary organic acids and plasma acyl-carnitine. We studied a cohort
of 11 RR-MAD patients, performing a battery of biochemical and
molecular tests to better characterise the metabolic disturbance of
this disease and to explore the pathophysiological events [1–3].
Biochemical alterations of pre-therapy patient muscles included:
(i) reduction in β-oxidation and in flavin-dependent enzymes (short
and medium-chain acyl coenzyme A dehydrogenases, complexes I
and II); (ii) reduction of FMN and FAD concentrations, (iii) increased
activity of mitochondrial FAD pyrophosphatase [1, 3], thus suggesting
an altered regulation of mitochondrial flavin cofactor homeostasis [4].
Proteomic investigation of muscle mitochondria in one RR-MAD
patient [3] revealed decrease or absence of several proteins. All these
deficiencies were completely rescued after riboflavin treatment.
Proteomic data indicate that the enzymatic defects are multiple,
coordinated, riboflavin-responsive and more extensive than pre-
viously described. In patients with RR-MAD the molecular defect is
still unknown. Recently it was described that RR-MAD is associated
with defects in electron transfer flavoprotein dehydrogenase (ETFDH)
gene in a large proportion of cases. Therefore we performed
molecular investigation by sequencing the ETFDH gene to identify
the defects in this group of RR-MAD patients. The genomic sequence
of each exon of ETFDH, including intron/exon boundaries has been
PCR-amplified for 30 cycles. The PCR products have been purified and
directly sequenced.
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